Literature DB >> 17958724

Prognostic significance of PTEN expression in esophageal squamous cell carcinoma from Linzhou City, a high incidence area of northern China.

D Chang1, T-Y Wang, H-C Li, J-C Wei, J-X Song.   

Abstract

Decreased expression of tumor suppressor gene PTEN has been reported to be a poor prognostic indicator in a variety of human malignant tumors. The purpose of this study was to clarify the roles of PTEN in esophageal squamous cell carcinoma (ESCC) and the prognostic significance of PTEN protein expression. Sixty-four patients from a high incidence area of northern China who underwent esophagectomy for ESCC between January 1998 and December 1999 enrolled in this study. PTEN expression was assessed by immunohistochemistry in 64 primary cancers and 64 paired normal esophageal epithelium tissues. The positive rate and staining grade of PTEN protein expression was lower in the esophageal cancers than in paired adjacent normal esophageal epithelium (P < 0.001). PTEN expression correlated with tumor differentiation (P = 0.001), tumor infiltration depth (P = 0.015) and pTNM staging (P = 0.048). The 5-year survival rate in patients with PTEN positive expression was 82% compared to 39% in patients with PTEN negative expression (P = 0.0019). Our results show that the expression of PTEN is decreased in ESCC compared to normal esophageal epithelium. Therefore, PTEN may play an important role in carcinogenesis and the progression of ESCC in a high incidence area of northern China, and PTEN could serve as an important factor to predict clinical outcome and prognosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17958724     DOI: 10.1111/j.1442-2050.2007.00695.x

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  8 in total

1.  PTEN gene is infrequently hypermethylated in human esophageal squamous cell carcinoma.

Authors:  Zhenguo Sun; Na Ji; Mingming Bi; Shuai Wang; Xiangyan Liu; Zhou Wang
Journal:  Tumour Biol       Date:  2015-02-28

2.  Clinical implications of PTEN and VEGF expression status, as well as microvessel density in esophageal squamous cell carcinoma.

Authors:  Wei Qu; Jin-Dong Fu; Fang Yang; Gong-Li Yang; Ya-Li Zhang; Xin-Ying Wang; Hong-Xiang Gu; Hai-Yan Zhang; Ling Wang
Journal:  Oncol Lett       Date:  2015-06-29       Impact factor: 2.967

3.  Mutational analysis of the PTEN gene and its effects in esophageal squamous cell carcinoma.

Authors:  Guiqin Hou; Zhaoming Lu; Mingyue Liu; Hongmin Liu; Lexun Xue
Journal:  Dig Dis Sci       Date:  2010-11-30       Impact factor: 3.199

Review 4.  Genomic and Epigenomic Aberrations in Esophageal Squamous Cell Carcinoma and Implications for Patients.

Authors:  De-Chen Lin; Ming-Rong Wang; H Phillip Koeffler
Journal:  Gastroenterology       Date:  2017-07-27       Impact factor: 33.883

5.  Screening for EGFR Mutations in Patients with Head and Neck Cancer Treated with Gefitinib on a Compassionate-Use Program: A Hellenic Cooperative Oncology Group Study.

Authors:  Samuel Murray; Mattheos Bobos; Nikolaos Angouridakis; Angelos Nikolaou; Helena Linardou; Evangelia Razis; George Fountzilas
Journal:  J Oncol       Date:  2011-01-03       Impact factor: 4.375

6.  MiR-130b plays an oncogenic role by repressing PTEN expression in esophageal squamous cell carcinoma cells.

Authors:  Tingting Yu; Risheng Cao; Shuo Li; Mingen Fu; Lihua Ren; Weixu Chen; Hong Zhu; Qiang Zhan; Ruihua Shi
Journal:  BMC Cancer       Date:  2015-01-31       Impact factor: 4.430

Review 7.  Esophageal Cancer: Genomic and Molecular Characterization, Stem Cell Compartment and Clonal Evolution.

Authors:  Ugo Testa; Germana Castelli; Elvira Pelosi
Journal:  Medicines (Basel)       Date:  2017-09-14

8.  PTK7, a Catalytically Inactive Receptor Tyrosine Kinase, Increases Oncogenic Phenotypes in Xenograft Tumors of Esophageal Squamous Cell Carcinoma KYSE-30 Cells.

Authors:  Won-Sik Shin; Mi-Kyung Park; Jae Hoon Kim; Si Won Oh; Ji-Yun Jang; Ho Lee; Seung-Taek Lee
Journal:  Int J Mol Sci       Date:  2022-02-21       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.